ExpreS2ion Biotechnologies ApSAktiv
Økonomiske nøgletal
Nøgletal
2025Balancens sammensætning
Selskabsskat
indkomstår 2024Kilde: Skattestyrelsens offentlige skattelister for selskaber. Beregnet skat for indkomståret; kan være lavere end 22 % af indkomsten, fx ved skat betalt i udlandet. sktst.dk
Regnskabstal2017–2025
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Balance — aktiver | |||||||||
| Likvide beholdninger | 979.000 | 424.522 | 2.323.836 | 75.423.447 | 23.188.830 | 74.274.414 | 36.402.465 | 43.372.115 | 32.597.636 |
| Omsætningsaktiver i alt | 4.172.000 | 3.849.857 | 6.243.630 | 80.019.681 | 104.668.819 | 89.368.587 | 45.137.688 | 53.119.966 | 39.362.176 |
| Anlægsaktiver i alt | 987.000 | 1.205.405 | 1.538.537 | 1.730.687 | 1.709.741 | 1.648.802 | 5.072.513 | 4.853.785 | 4.194.365 |
| Aktiver i alt | 5.159.000 | 5.055.262 | 7.782.167 | 81.750.368 | 106.378.560 | 91.017.389 | 50.210.201 | 57.973.751 | 43.556.541 |
| Balance — passiver | |||||||||
| Kortfristede gældsforpligtelser | 4.965.000 | 14.430.794 | 5.880.920 | 11.586.411 | 6.599.757 | 21.147.885 | 7.314.196 | 24.240.730 | 19.018.218 |
| Langfristede gældsforpligtelser | 4.775.000 | 4.957.636 | 5.585.315 | 5.814.250 | 2.511.040 | 1.337.594 | 964.681 | 934.631 | 588.061 |
| Gældsforpligtelser i alt | 9.740.000 | 19.388.430 | 11.466.235 | 17.400.661 | 9.110.797 | 22.485.479 | 8.278.877 | 25.175.361 | 19.606.279 |
| Selskabskapital | 531.000 | 530.835 | 530.835 | 530.835 | 530.835 | 530.835 | 530.835 | 530.835 | 530.835 |
| Overført resultat | -5.112.000 | -14.864.003 | -4.214.903 | 63.818.872 | 96.736.928 | 68.001.075 | 41.400.489 | 32.267.555 | 23.419.427 |
| Årets resultat | -5.132.000 | -9.751.775 | -8.611.095 | -18.365.182 | -27.224.687 | -79.149.270 | -55.629.460 | -19.830.535 | -21.948.253 |
| Egenkapital i alt | -4.581.000 | -14.333.168 | -3.684.068 | 64.349.707 | 97.267.763 | 68.531.910 | 41.931.324 | 32.798.390 | 23.950.262 |
| Resultatopgørelse | |||||||||
| Bruttofortjeneste | 2.508.000 | 510.008 | 2.813.678 | -7.043.885 | -7.806.372 | -57.917.073 | -38.920.365 | -24.035.211 | -9.158.236 |
| Resultat af primær drift | -5.521.000 | -9.174.637 | -8.515.782 | — | -29.790.995 | -84.344.310 | -64.610.581 | -40.310.696 | -25.968.705 |
| EBITDA | -5.312.000 | -8.826.861 | -8.039.507 | — | -29.196.239 | -83.804.863 | -63.882.182 | -39.551.627 | -25.292.036 |
| Resultat før skat | -6.200.000 | -10.980.575 | -10.021.812 | -20.405.982 | -29.733.187 | -84.649.270 | -61.130.267 | -25.330.535 | -25.993.878 |
| Årets resultat | -5.132.000 | -9.751.775 | -8.611.095 | -18.365.182 | -27.224.687 | -79.149.270 | -55.629.460 | -19.830.535 | -21.948.253 |
| Personaleomkostninger | 7.820.000 | 9.336.869 | 10.853.185 | 11.156.619 | 21.383.769 | 25.887.790 | 24.961.817 | 15.516.416 | 16.133.800 |
| Af- og nedskrivninger | 209.000 | 347.776 | 476.275 | 521.033 | 594.756 | 539.447 | 728.399 | 759.069 | 676.669 |
| Andre nøgletal | |||||||||
| Ansatte | 11 | 15 | 15 | 16 | 21 | 27 | 26 | 17 | 18 |
En streg (—) betyder, at der ikke er indsendt årsrapport, eller at posten ikke fremgår af den; 0 er et nul angivet i årsrapporten.
Om virksomheden
Årsrapport 2025The company's activities are within contract based as well as own research & development of biotechnological products within diagnostics, vaccines and immunotherapy. For more information see the company's website www.expres2ionbio.com
The income statement for the period 01.01.25 - 31.12.25 shows a profit/loss of DKK -21,948,253 against DKK -19,831k for the period 01.01.24 - 31.12.24. The balance sheet shows equity of DKK 23,950,262.Financial Position and liquidity resourcesThe Company's ability to continue as a going concern is depending on ExpreS2ion Biotech Holding AB's (the parent company) ability to raise additional funds. Refer to note 2 as basis for the assessment that the Board of Directors and the Executive Management have prepared the financial statements based on a going concern assumption.
Uddrag af ledelsesberetningen i den seneste årsrapport.